Global CRISPR/Cas9 Market Size, Status, Research and Forecast 2019-2025

Published On: Aug 2019

Format: PDF

Publisher: QY Research

Pages: 100

Report ID: 49839

CRISPR is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes. Cas9 is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases.
In 2018, the global CRISPR/Cas9 market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global CRISPR/Cas9 status, future forecast, growth opportunity, key market and key players. The study objectives are to present the CRISPR/Cas9 development in United States, Europe and China.

The key players covered in this study
Caribou Biosciences
Integrated DNA Technologies (IDT)
CRISPR Therapeutics
Merck
Mirus Bio
Editas Medicine
Takara Bio
Thermo Fisher Scientific
Horizon Discovery Group
Intellia Therapeutics
Agilent Technologies
Cellecta
GenScript
GeneCopoeia
Synthego

Market segment by Type, the product can be split into
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering

Market segment by Application, split into
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global CRISPR/Cas9 status, future forecast, growth opportunity, key market and key players.
To present the CRISPR/Cas9 development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of CRISPR/Cas9 are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global CRISPR/Cas9 Market Size Growth Rate by Type (2014-2025)
1.4.2 Genome Editing
1.4.3 Genetic engineering
1.4.4 gRNA Database/Gene Librar
1.4.5 CRISPR Plasmid
1.4.6 Human Stem Cells
1.4.7 Genetically Modified Organisms/Crops
1.4.8 Cell Line Engineering
1.5 Market by Application
1.5.1 Global CRISPR/Cas9 Market Share by Application (2014-2025)
1.5.2 Biotechnology Companies
1.5.3 Pharmaceutical Companies
1.5.4 Academic Institutes
1.5.5 Research and Development Institutes
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 CRISPR/Cas9 Market Size
2.2 CRISPR/Cas9 Growth Trends by Regions
2.2.1 CRISPR/Cas9 Market Size by Regions (2014-2025)
2.2.2 CRISPR/Cas9 Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 CRISPR/Cas9 Market Size by Manufacturers
3.1.1 Global CRISPR/Cas9 Revenue by Manufacturers (2014-2019)
3.1.2 Global CRISPR/Cas9 Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global CRISPR/Cas9 Market Concentration Ratio (CR5 and HHI)
3.2 CRISPR/Cas9 Key Players Head office and Area Served
3.3 Key Players CRISPR/Cas9 Product/Solution/Service
3.4 Date of Enter into CRISPR/Cas9 Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global CRISPR/Cas9 Market Size by Type (2014-2019)
4.2 Global CRISPR/Cas9 Market Size by Application (2014-2019)

5 United States
5.1 United States CRISPR/Cas9 Market Size (2014-2019)
5.2 CRISPR/Cas9 Key Players in United States
5.3 United States CRISPR/Cas9 Market Size by Type
5.4 United States CRISPR/Cas9 Market Size by Application

6 Europe
6.1 Europe CRISPR/Cas9 Market Size (2014-2019)
6.2 CRISPR/Cas9 Key Players in Europe
6.3 Europe CRISPR/Cas9 Market Size by Type
6.4 Europe CRISPR/Cas9 Market Size by Application

7 China
7.1 China CRISPR/Cas9 Market Size (2014-2019)
7.2 CRISPR/Cas9 Key Players in China
7.3 China CRISPR/Cas9 Market Size by Type
7.4 China CRISPR/Cas9 Market Size by Application

8 Japan
8.1 Japan CRISPR/Cas9 Market Size (2014-2019)
8.2 CRISPR/Cas9 Key Players in Japan
8.3 Japan CRISPR/Cas9 Market Size by Type
8.4 Japan CRISPR/Cas9 Market Size by Application

9 Southeast Asia
9.1 Southeast Asia CRISPR/Cas9 Market Size (2014-2019)
9.2 CRISPR/Cas9 Key Players in Southeast Asia
9.3 Southeast Asia CRISPR/Cas9 Market Size by Type
9.4 Southeast Asia CRISPR/Cas9 Market Size by Application

10 India
10.1 India CRISPR/Cas9 Market Size (2014-2019)
10.2 CRISPR/Cas9 Key Players in India
10.3 India CRISPR/Cas9 Market Size by Type
10.4 India CRISPR/Cas9 Market Size by Application

11 Central & South America
11.1 Central & South America CRISPR/Cas9 Market Size (2014-2019)
11.2 CRISPR/Cas9 Key Players in Central & South America
11.3 Central & South America CRISPR/Cas9 Market Size by Type
11.4 Central & South America CRISPR/Cas9 Market Size by Application

12 International Players Profiles
12.1 Caribou Biosciences
12.1.1 Caribou Biosciences Company Details
12.1.2 Company Description and Business Overview
12.1.3 CRISPR/Cas9 Introduction
12.1.4 Caribou Biosciences Revenue in CRISPR/Cas9 Business (2014-2019)
12.1.5 Caribou Biosciences Recent Development
12.2 Integrated DNA Technologies (IDT)
12.2.1 Integrated DNA Technologies (IDT) Company Details
12.2.2 Company Description and Business Overview
12.2.3 CRISPR/Cas9 Introduction
12.2.4 Integrated DNA Technologies (IDT) Revenue in CRISPR/Cas9 Business (2014-2019)
12.2.5 Integrated DNA Technologies (IDT) Recent Development
12.3 CRISPR Therapeutics
12.3.1 CRISPR Therapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 CRISPR/Cas9 Introduction
12.3.4 CRISPR Therapeutics Revenue in CRISPR/Cas9 Business (2014-2019)
12.3.5 CRISPR Therapeutics Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 CRISPR/Cas9 Introduction
12.4.4 Merck Revenue in CRISPR/Cas9 Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Mirus Bio
12.5.1 Mirus Bio Company Details
12.5.2 Company Description and Business Overview
12.5.3 CRISPR/Cas9 Introduction
12.5.4 Mirus Bio Revenue in CRISPR/Cas9 Business (2014-2019)
12.5.5 Mirus Bio Recent Development
12.6 Editas Medicine
12.6.1 Editas Medicine Company Details
12.6.2 Company Description and Business Overview
12.6.3 CRISPR/Cas9 Introduction
12.6.4 Editas Medicine Revenue in CRISPR/Cas9 Business (2014-2019)
12.6.5 Editas Medicine Recent Development
12.7 Takara Bio
12.7.1 Takara Bio Company Details
12.7.2 Company Description and Business Overview
12.7.3 CRISPR/Cas9 Introduction
12.7.4 Takara Bio Revenue in CRISPR/Cas9 Business (2014-2019)
12.7.5 Takara Bio Recent Development
12.8 Thermo Fisher Scientific
12.8.1 Thermo Fisher Scientific Company Details
12.8.2 Company Description and Business Overview
12.8.3 CRISPR/Cas9 Introduction
12.8.4 Thermo Fisher Scientific Revenue in CRISPR/Cas9 Business (2014-2019)
12.8.5 Thermo Fisher Scientific Recent Development
12.9 Horizon Discovery Group
12.9.1 Horizon Discovery Group Company Details
12.9.2 Company Description and Business Overview
12.9.3 CRISPR/Cas9 Introduction
12.9.4 Horizon Discovery Group Revenue in CRISPR/Cas9 Business (2014-2019)
12.9.5 Horizon Discovery Group Recent Development
12.10 Intellia Therapeutics
12.10.1 Intellia Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 CRISPR/Cas9 Introduction
12.10.4 Intellia Therapeutics Revenue in CRISPR/Cas9 Business (2014-2019)
12.10.5 Intellia Therapeutics Recent Development
12.11 Agilent Technologies
12.12 Cellecta
12.13 GenScript
12.14 GeneCopoeia
12.15 Synthego

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details